Effects of a Specific Substance in Smokers
- Conditions
- Smoking
- Interventions
- Drug: PlaceboDrug: Study Agent
- Registration Number
- NCT04281979
- Lead Sponsor
- Oregon Health and Science University
- Brief Summary
Although rates of cigarette use are declining, the proportion of nondaily smokers is rising, particularly among young adults. Among young adults, nondaily smoking is associated with negative health consequences and, for some, may lead to the establishment of life-long smoking patterns. The goal of this project is to understand the behavioral, psychological and neurobiological factors that contribute to cigarette use in nondaily smokers to aid the development of tailored evidence-based interventions.
- Detailed Description
The purpose of this study is to investigate the neurobiological mechanisms associated with cigarette use in young nondaily smokers (ages 21-25). Nondaily smokers experience fewer symptoms of cigarette withdrawal than daily smokers; however, they still experience difficulty quitting. Since smoking cessation before the age of 30 substantially attenuates the long-term health consequences associated with smoking, understanding the factors that motivate cigarette use in young nondaily smokers and developing tailored interventions will be critical for curbing cigarette use and improving public health. The proposed project will use functional magnetic resonance imaging (fMRI) to examine how other substances (e.g. stimulates, sedatives, or analgesics) impact brain function and will assess the extent to which substance-induced changes in brain function correlate with impulsive choice, cigarette craving, and craving regulation in young adults. Furthermore, the investigators will assess how substance-induced changes in brain function, impulsivity, craving, and capacity for craving regulation predict cigarette use over the course of 1 year.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 60
- Participants must be 21-40 years old
- Right-handed
- Fluent in English
- Report smoking cigarettes or e-cigarettes 1-27 days in the past month
- Report binge drinking based on NIAAA criteria (5 or more drinks per occasion for males, 4 or more drinks per occasion for females) at least 1 time in the past 90 days without adverse incident
- Seeking treatment for substance use (e.g. nicotine or alcohol use)
- Moderate or Severe Nicotine Dependence
- Current alcohol use disorder
- Illicit substance use other than marijuana use in the past year
- Marijuana use more than 10 times in the past year
- Major neurological or medical illness - Significant head trauma - Current use of medication affecting the central nervous system
- MRI contraindications (e.g. irremovable metal on the body or pregnancy)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Placebo Placebo - Study Agent Study Agent -
- Primary Outcome Measures
Name Time Method Impulsivity Immediately after beverage/capsule consumption Impulsivity will be measured by assessing behavior on a temporal discounting task.
Resting State Functional Connectivity 35 minutes after beverage/capsule consumption Brain function will be measured while participants are resting using functional magnetic resonance imaging
Cigarette Craving and Associated Brain Activation 50 minutes after beverage/capsule consumption Brain function will be measured using functional magnetic resonance imaging while participants complete a Craving Regulation Task
Symptoms of Cigarette Dependence 1 year follow-up from baseline The Fagerström Test of Nicotine Dependence total score will be used to measure changes in cigarette dependence
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Oregon Health and Science University
🇺🇸Portland, Oregon, United States